Navigation Links
Cheryl Fossum Graham Joins Knopp Neurosciences as Head of Regulatory and Development Strategy
Date:10/3/2007

where she earned Phi Beta Kappa Honors.

About KNS-760704

KNS-760704 is an orally administered small molecule in clinical development by Knopp for the treatment of amyotrophic lateral sclerosis (ALS). The drug is an optical enantiomer of a selective, high affinity dopamine agonist marketed in other neurological indications. Both KNS-760704 and the marketed agonist demonstrate neuroprotective properties independent of dopamine receptor activity, but KNS-760704 exhibits greatly reduced dopamine receptor affinity. This makes it possible to clinically evaluate the potential neuroprotective activity of KNS-760704 over a broad dose range.

About ALS

Amyotrophic lateral sclerosis (ALS), often called Lou Gehrig's disease, is a rapid, universally fatal neurodegenerative disorder characterized by progressive muscle weakness and wasting. ALS affects adults in the prime of life and creates a substantial burden for caregivers. U.S. prevalence is nearly 30,000 and the incidence is 1.2 per 100,000. Only a single drug has been approved for the treatment of ALS. Life expectancy after symptom onset is usually three to five years.

About Knopp Neurosciences Inc.

Knopp Neurosciences (http://www.knoppneurosciences.com) is a drug discovery and development company focused on delivering breakthrough treatments for neurological disorders through innovation, experience, and partnership. The company's lead product candidate is KNS-760704, an orally bioavailable small molecule in development for the treatment of ALS. Knopp's leadership includes experienced neuroscience drug development and discovery executives formerly associated with major pharmaceutical companies. Knopp's financing has been led by Saturn Capital Inc. of Boston as placement agent and Saturn Partners II as lead funder.

This press release contains "forward-looking statements," including statements relating to Knopp's planned reg
'/>"/>

SOURCE Knopp Neurosciences Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
2. Rat joins list of cloned animals
3. Richard Gere Joins Indian Stars For Fight Against AIDS
4. Enbrel Joins with Methotrexate to Cure Rheumatoid Arthritis
5. Anoushka Joins Hands With WFP to Feed the Poor
6. India Joins Hands With Global Body for Vaccine Research
7. Another Statewide Organization Joins the Fight Against Assisted Suicide
8. Two-year-old Joins Mensa, Becomes Its Youngest Ever Genius
9. Handbook cum diary on regulatory information
10. Drug regulatory officials giving the nod for sale of Unapproved drug formulations in India
11. Tumor Suppressor p53s Contradictory Regulatory System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... Intermountain Healthcare of Salt ... Stratus Video Interpreting for on-demand medical ... and timely care for patients with limited ... video remote interpreting (VRI) services will supplement ... quickly access qualified medical interpretation in nearly ...
(Date:5/29/2015)... York, NY (PRWEB) May 29, 2015 ... USA Today, with a circulation of approximately 250,000 and ... distributed nationally, through a vast social media strategy, and ... outlets. To explore the digital version of the campaign, ... cover of the print publication. Inside, the actress, model ...
(Date:5/29/2015)... Mediaplanet has joined forces with Colorescience ... Skin Health is a cross-platform campaign with a national ... New York, Los Angeles, and Chicago, the campaign is ... counterpart will reach a national audience through one of ... Skin Health campaign and Colorescience, click here . ...
(Date:5/29/2015)... May 29, 2015 OncLive proudly announces ... dozen medical pioneers recognized by a panel of eminent ... of cancer treatment. Honorees will be introduced and celebrated ... Award Ceremony, held 8:30-11:00 p.m. CDT at The Chicago ... honorees are being recognized for groundbreaking accomplishments, in fields ...
(Date:5/29/2015)... May 29, 2015 Healthpointe is ... with specialists, physical therapy, and injections , For ... back and/or lower back pain, Healthpointe has a ... for herniated discs, disc protrusions and other causes ... , Healthpointe’s team of renowned surgeons are now ...
Breaking Medicine News(10 mins):Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 2Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 3Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 4Health News:Mediaplanet Launches “Skin Health” Campaign Featuring Colorescience 2Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 2Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 3Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 4Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 2Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 3
... Researchers from Harvard School of Public Health (HSPH), Massachusetts ... Research (NBER), and Providence Health & Services have found ... increases health care use, reduces financial strain on covered ... is the first study to evaluate the impact of ...
... today [Thursday 7 July] at the Annual Scientific Meeting of ... the Academic Unit of Primary Health Care, University of Bristol. ... 2008, uses HPV vaccine that is effective against the two ... offers 70 per cent protection against cervical cancer. However, ...
... 6, 2011) One consequence of the expanded access to ... shortfall in the necessary numbers of physicians and other advanced ... issue of the Journal of the American College of ... the combined workforce of physicians, advance practice nurses, and physician ...
... HealthDay Reporter , WEDNESDAY, July 6 (HealthDay ... multiple sclerosis have been dimmed by recent research in ... found no support for prior studies connecting breast-feeding with ... disorder commonly known as MS. Instead, they ...
... , WEDNESDAY, July 6 (HealthDay News) -- Airline pilots ... debilitating fatigue that could hamper their flying performance, a ... U.S. Federal Aviation Administration should find ways to reduce ... to the report from the U.S. National Research Council. ...
... HealthDay Reporter , WEDNESDAY, July 6 (HealthDay News) -- ... rise in various parts of the country, and this one ... by a microscopic parasite that attacks blood cells, causing flu-like ... Lyme disease, which is caused by bacteria, babesia microti parasites ...
Cached Medicine News:Health News:Medicaid increases use of health care, decreases financial strain, improves health 2Health News:Medicaid increases use of health care, decreases financial strain, improves health 3Health News:Lack of clarity about HPV vaccine and the need for cervical cancer screening 2Health News:Future labor shortfalls of medical professionals predicted due to new demands of health-care reform 2Health News: Breast-Feeding May Not Protect Moms Against MS Relapse 2Health News: Breast-Feeding May Not Protect Moms Against MS Relapse 3Health News:Long Commutes for Pilots May Hamper Flying Performance: Study 2Health News:Long Commutes for Pilots May Hamper Flying Performance: Study 3Health News:Long Commutes for Pilots May Hamper Flying Performance: Study 4Health News:A Deadly New Reason to Avoid Deer Ticks 2Health News:A Deadly New Reason to Avoid Deer Ticks 3
(Date:5/29/2015)... 2015 Educating the community continues to ... the Advancement of Wound Care (AAWC), which was ... AAWC,s corporate partners, the Association provides medical professionals ... AAWC website at http://aawconline.org/education-for-the-generalist/ . The portal ... links to various CME/CEU educational programs. This education ...
(Date:5/28/2015)... HOUSTON , May 28, 2015 /PRNewswire/ - ESSA Pharma ... results for the second quarter and three and six months ... in Canadian dollars and in accordance with International Financial Reporting ... ESSA recorded a net loss of $5.9 million ($0.35 per ... (Q2-2015), compared to a net loss of $0.4 million ($0.03 ...
(Date:5/28/2015)... 2015  Maetrics ( http://maetrics.com ), a leading international ... up a successful conference, "The cost of non-compliance -- How ... in Zurich . ... Switzerland -based team, experts provided insights ... field to an exclusive local audience. The event was ...
Breaking Medicine Technology:The Association for the Advancement of Wound Care Educates the Public 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 3Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 4Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 5Maetrics Hosts Innovative Medical Cluster Event in Switzerland 2
... 5 GlaxoSmithKline [NYSE: GSK] today announced that ... Oncologic Drugs Advisory Committee (ODAC) voted unanimously in ... the panel voted that the benefit-to-risk profile is ... (RCC). Pazopanib is an investigational, oral treatment for ...
... Oct. 5 In a settlement that is essentially ... (NLRB), which conducted a two-month investigation into massive illegal ... company, the giant HCA chain, have pledged to end ... of registered nurses. , The settlement stems from a ...
Cached Medicine Technology:GlaxoSmithKline Receives Unanimous FDA Panel Approval Recommendation for VOTRIENT(TM) 2GlaxoSmithKline Receives Unanimous FDA Panel Approval Recommendation for VOTRIENT(TM) 3Faced With Federal Prosecution, MountainView Agrees to Stop Harassment of RNs in Settlement With Labor Board 2
... mg/kg sulfate (SO 4 ) ≤ 1000 mg/kg Cation ... Co ≤ 5 mg/kg Cr ≤ 10 mg/kg Cu ... 5 mg/kg Mg ≤ 5 mg/kg Mn ≤ 5 ... Pb ≤ 5 mg/kg Zn ≤ 5 mg/kg Special ...
Inquire...
... A low temperature agarose for special ... Optimal for in-gel restriction digestion/ligation and DNA ... manageable clear gel that provides excellent resolution ... 65°C and remains fluid at 37°C for ...
... Agarose 3:1 HRB™ (High Resolution Blend), ... to provide high resolution of small nucleic ... analysis of DNA fragmanets less than 1,000 ... patterns without smearing of high background fluorescence. ...
Medicine Products: